7/12/2019 Contest update
It was a big week for stocks with the Dow, S&P 500 and Nasdaq Composite all making record highs. Unfortunately, however, general concerns about drug price controls as well as Illumina’s tsuris soured investor’s appetite for biotechs.
At Friday’s close, the Contest median was up 19.89% YTD (vs. up 21.50% a week ago), the Nasdaq Biotech Index (NBI) was up 8.88% YTD (vs. up 12.88% a week ago) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 19.05% YTD (vs. up 21.01% a week ago), while the Nasdaq Composite Index (NCI) was up 24.25% YTD (vs. up 23.01% YTD a week ago).
BULBA’s portfolio remained in first place with a 105.98% YTD gain. ANDRE’s portfolio, up 75.86% YTD, climbed into second place while KMASTR’s portfolio, up 74.56% YTD, slipped to third place.
At Friday's close, 32 of the 39 Contest portfolios were still in the green, while 28 were beating the NBI and 21 were still beating the SPSIBI.
The 167 Contest stock picks have an average YTD gain of 26.32% and a median YTD gain of 12.57%.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None.
(All corrections, especially adjustments for splits & mergers, greatly appreciated.)
Enjoy a safe & relaxing summer weekend biotechies!
Peace & good health,
Bulba
7/12/19
Rank Name Profit/Loss
1 BULBA 105,982
2 ANDRE 75,862
3 KMASTR 74,558
4 BMAZ 71,262
5 ARTHUR 62,826
6 OHMS 59,842
7 HOOD 54,474
8 TRONKA 49,063
9 BIOCQR 46,813
10 RKRW 43,881
Week's Top 5 Gainers
Symbol 7/5/19 7/12/19 Wk.%chg.
SNGX 0.780 0.980 25.64%
ADVM 12.160 14.970 23.11%
SRRA 0.565 0.650 14.98%
AXGT 6.420 7.380 14.95%
EIGR 10.100 11.290 11.78%
Week's Worst 5 Losers
Symbol 7/5/19 7/12/19 Wk.%chg.
ILMN 378.230 305.050 -19.35%
ITCI 13.460 11.190 -16.86%
AGRX 1.510 1.290 -14.57%
ADXS 1.790 1.565 -12.57%
SENS 1.830 1.620 -11.48%
|
